Category - Feature

Feature

DxTerity bringing at-home precision medicine to patients with autoimmune diseases

By Len Zehr Closely-held DxTerity has developed the first affordable diagnostics platform for at-home monitoring of autoimmune disease activity and response to drug treatment, with tests that use longitudinal gene...

March 12, 2019

Feature

In Conversation with Gregory Montalbano of MIDI

By Len Zehr As a principal of closely-held MIDI Medical Product Development, Greg Montalbano has a unique background in industrial design, usability/ergonomics and manufacturing with over 25 years of experience...

March 5, 2019

Feature

PharmaJet injection devices creating needle-free world

By Len Zehr Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development. “We are at...

February 26, 2019

Feature

Lineagen champions clinical information solutions for autism spectrum disorders and other neurodevelopmental conditions

By Len Zehr Closely-held Lineagen has developed and commercialized a comprehensive portfolio of behavioral screening and genetic tests for autism spectrum disorders (ASD) and other forms of childhood neurodevelopmental...

February 19, 2019

Feature

ImpediMed sees revenue upswing from new SaaS business model

ImpediMed’s (ASX:IPD) transition to a software-as-a-service (SaaS) subscription business model in 2018, in conjunction with the introduction of the SOZO Digital Health Platform, is already paying off on the top line.

February 12, 2019

Feature

Interface Biologics to focus future growth in biotech with local drug delivery platform

Closely-held Interface Biologics, best known for improving the safety and efficacy of medical devices through its Endexo surface modification technology, is pegging its future growth on biotech, with an initial focus on...

February 5, 2019

Feature

Karius diagnostic test enabling precision medicine for infectious diseases

Closely-held Karius has developed and commercialized a next-generation sequencing test that can identify and quantify microbial cell-free DNA from more than 1,300 bacteria, viruses, fungi and parasites using a non...

January 29, 2019

Feature

Novavax to report key vaccine data in first quarter

Novavax (NASDAQ:NVAX) is scheduled to report pivotal data in the current quarter for ResVax, its RSV (respiratory syncytial virus) F vaccine, using aluminum phosphate as an adjuvant, in infants via maternal immunization.

January 22, 2019

Feature

Titan Pharma relaunch of Probuphine paying early dividends

Titan Pharmaceuticals’ (NASDAQ:TTNP) relaunch of its Probuphine implant for the long-term maintenance treatment of opioid use disorder (OUD) demonstrated promising results with a meaningful increase in product shipments...

January 15, 2019

Feature

BeyondSpring readies NDA filings for Plinabulin in U.S. and China

BeyondSpring (NASDAQ:BYSI) is preparing to file NDAs with the China FDA during the next six months for its lead asset, first-in-class agent Plinabulin, for the treatment of non-small cell lung cancer (NSCLC) and...

January 8, 2019

Category - Feature

DxTerity bringing at-home precision medicine to patients with autoimmune diseases

In Conversation with Gregory Montalbano of MIDI

PharmaJet injection devices creating needle-free world

Lineagen champions clinical information solutions for autism spectrum disorders and other neurodevelopmental conditions

ImpediMed sees revenue upswing from new SaaS business model

Interface Biologics to focus future growth in biotech with local drug delivery platform

Karius diagnostic test enabling precision medicine for infectious diseases

Novavax to report key vaccine data in first quarter

Titan Pharma relaunch of Probuphine paying early dividends

BeyondSpring readies NDA filings for Plinabulin in U.S. and China

General

More